Galderma Group AG Registered Shares

GALD: XSWX (CHE)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
P@BLOCK|p@j<LOCK|YN#J@P

Galderma: Impressive Revenue Growth Against Favorable Comparable; Shares Expensive

Galderma’s constant-currency sales rose 25.5% in the first quarter, with strong growth across all segments. Results came in above company-compiled consensus estimates across the board. Shares rose 7% intraday on April 23.

Sponsor Center